A detailed history of Engineers Gate Manager LP transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 12,686 shares of SELB stock, worth $10,656. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,686
Previous 12,686 -0.0%
Holding current value
$10,656
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.67 - $1.35 $8,499 - $17,126
12,686 New
12,686 $8,000
Q1 2023

May 15, 2023

SELL
$1.15 - $1.89 $205 - $338
-179 Reduced 0.97%
18,222 $25,000
Q4 2022

Feb 14, 2023

SELL
$0.96 - $1.6 $638 - $1,064
-665 Reduced 3.49%
18,401 $20,000
Q3 2022

Nov 14, 2022

SELL
$1.33 - $2.6 $60,147 - $117,582
-45,224 Reduced 70.34%
19,066 $31,000
Q2 2022

Aug 15, 2022

BUY
$0.67 - $1.4 $33,471 - $69,939
49,957 Added 348.55%
64,290 $84,000
Q1 2022

May 16, 2022

BUY
$1.23 - $3.31 $17,629 - $47,442
14,333 New
14,333 $18,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.